Stock comparison

ABTvsHCA

Abbott LaboratoriesvsHCA Healthcare Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ABT

Abbott Laboratories

$91.7

-26.39%

Health Care$161.5BNYSE

HCA

HCA Healthcare Inc

$474.03

+0.46%

Health Care$105.5BNYSE

60-day price, rebased to 100

ABT -15.89% · HCA -4.59%

Round-by-round

ABT 3·HCA 3

EdgeHCA

Valuation upside

-14.50% vs +55.10% to DCF fair value

EdgeABT

Balance-sheet strength

Altman Z 4.61 vs 2.75

EdgeHCA

Fundamental quality

Piotroski 6.00 vs 7.00 (of 9)

EdgeABT

Growth + margins

Rule-of-40 22.40 vs 17.30

EdgeHCA

60-day momentum

-15.89% vs -4.59% price return

EdgeABT

Market-cap liquidity

$161.5B vs $105.5B

Verdict

Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onABTorHCA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.